Northgate Healthcare Limited - Limited company accounts 18.2

Northgate Healthcare Limited - Limited company accounts 18.2


IRIS Accounts Production v19.1.1.57 05773858 Board of Directors 1.1.18 31.12.18 31.12.18 the provision of residential care services. false true true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure057738582017-12-31057738582018-12-31057738582018-01-012018-12-31057738582016-12-31057738582017-01-012017-12-31057738582017-12-3105773858ns15:EnglandWales2018-01-012018-12-3105773858ns14:PoundSterling2018-01-012018-12-3105773858ns10:Director12018-01-012018-12-3105773858ns10:PrivateLimitedCompanyLtd2018-01-012018-12-3105773858ns10:FRS1022018-01-012018-12-3105773858ns10:Audited2018-01-012018-12-3105773858ns10:LargeMedium-sizedCompaniesRegimeForDirectorsReport2018-01-012018-12-3105773858ns10:LargeMedium-sizedCompaniesRegimeForAccounts2018-01-012018-12-3105773858ns10:FullAccounts2018-01-012018-12-310577385812018-01-012018-12-3105773858ns10:OrdinaryShareClass12018-01-012018-12-3105773858ns10:Director22018-01-012018-12-3105773858ns10:Director32018-01-012018-12-3105773858ns10:CompanySecretary12018-01-012018-12-3105773858ns10:RegisteredOffice2018-01-012018-12-3105773858ns5:CurrentFinancialInstruments2018-12-3105773858ns5:CurrentFinancialInstruments2017-12-3105773858ns5:Non-currentFinancialInstruments2018-12-3105773858ns5:Non-currentFinancialInstruments2017-12-3105773858ns5:ShareCapital2018-12-3105773858ns5:ShareCapital2017-12-3105773858ns5:RevaluationReserve2018-12-3105773858ns5:RevaluationReserve2017-12-3105773858ns5:RetainedEarningsAccumulatedLosses2018-12-3105773858ns5:RetainedEarningsAccumulatedLosses2017-12-3105773858ns5:ShareCapital2016-12-3105773858ns5:RetainedEarningsAccumulatedLosses2016-12-3105773858ns5:RevaluationReserve2016-12-3105773858ns5:RetainedEarningsAccumulatedLosses2017-01-012017-12-3105773858ns5:RevaluationReserve2017-01-012017-12-3105773858ns5:RetainedEarningsAccumulatedLosses2018-01-012018-12-3105773858ns5:RevaluationReserve2018-01-012018-12-3105773858ns5:IntangibleAssetsOtherThanGoodwill2018-01-012018-12-3105773858ns5:LandBuildingsns5:OwnedOrFreeholdAssets2018-01-012018-12-3105773858ns5:FurnitureFittings2018-01-012018-12-3105773858ns5:MotorVehicles2018-01-012018-12-3105773858ns5:ComputerEquipment2018-01-012018-12-3105773858ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2018-01-012018-12-3105773858ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2017-01-012017-12-3105773858ns5:OwnedAssets2018-01-012018-12-3105773858ns5:OwnedAssets2017-01-012017-12-3105773858ns5:LeasedAssets2018-01-012018-12-3105773858ns5:LeasedAssets2017-01-012017-12-3105773858ns5:NetGoodwill2018-01-012018-12-3105773858ns5:NetGoodwill2017-01-012017-12-3105773858ns5:PatentsTrademarksLicencesConcessionsSimilar2018-01-012018-12-3105773858ns5:PatentsTrademarksLicencesConcessionsSimilar2017-01-012017-12-310577385812018-01-012018-12-310577385812017-01-012017-12-3105773858ns5:HirePurchaseContracts2018-01-012018-12-3105773858ns5:HirePurchaseContracts2017-01-012017-12-3105773858ns10:OrdinaryShareClass12017-01-012017-12-3105773858ns5:NetGoodwill2017-12-3105773858ns5:PatentsTrademarksLicencesConcessionsSimilar2017-12-3105773858ns5:NetGoodwill2018-12-3105773858ns5:PatentsTrademarksLicencesConcessionsSimilar2018-12-3105773858ns5:NetGoodwill2017-12-3105773858ns5:PatentsTrademarksLicencesConcessionsSimilar2017-12-3105773858ns5:LandBuildings2017-12-3105773858ns5:FurnitureFittings2017-12-3105773858ns5:MotorVehicles2017-12-3105773858ns5:ComputerEquipment2017-12-3105773858ns5:LandBuildings2018-01-012018-12-3105773858ns5:LandBuildings2018-12-3105773858ns5:FurnitureFittings2018-12-3105773858ns5:MotorVehicles2018-12-3105773858ns5:ComputerEquipment2018-12-3105773858ns5:LandBuildings2017-12-3105773858ns5:FurnitureFittings2017-12-3105773858ns5:MotorVehicles2017-12-3105773858ns5:ComputerEquipment2017-12-3105773858ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2017-12-3105773858ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2018-01-012018-12-3105773858ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2018-12-3105773858ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2017-12-3105773858ns5:CurrentFinancialInstrumentsns5:WithinOneYear2018-12-3105773858ns5:CurrentFinancialInstrumentsns5:WithinOneYear2017-12-3105773858ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2018-12-3105773858ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2017-12-3105773858ns5:BetweenTwoFiveYearsns5:Non-currentFinancialInstruments2018-12-3105773858ns5:BetweenTwoFiveYearsns5:Non-currentFinancialInstruments2017-12-3105773858ns5:HirePurchaseContractsns5:WithinOneYear2018-12-3105773858ns5:HirePurchaseContractsns5:WithinOneYear2017-12-3105773858ns5:BetweenOneFiveYearsns5:HirePurchaseContracts2018-12-3105773858ns5:BetweenOneFiveYearsns5:HirePurchaseContracts2017-12-3105773858ns5:HirePurchaseContracts2018-12-3105773858ns5:HirePurchaseContracts2017-12-3105773858ns5:CurrentFinancialInstrumentsns5:HirePurchaseContractsns5:WithinOneYear2018-12-3105773858ns5:CurrentFinancialInstrumentsns5:HirePurchaseContractsns5:WithinOneYear2017-12-3105773858ns5:WithinOneYear2018-12-3105773858ns5:WithinOneYear2017-12-3105773858ns5:BetweenOneFiveYears2018-12-3105773858ns5:BetweenOneFiveYears2017-12-3105773858ns5:AllPeriods2018-12-3105773858ns5:AllPeriods2017-12-3105773858ns5:Secured2018-12-3105773858ns5:Secured2017-12-3105773858ns5:DeferredTaxation2017-12-3105773858ns5:DeferredTaxation2018-12-3105773858ns10:OrdinaryShareClass12018-12-3105773858ns5:RetainedEarningsAccumulatedLosses2017-12-3105773858ns5:RevaluationReserve2017-12-31


REGISTERED NUMBER: 05773858 (England and Wales)















STRATEGIC REPORT, REPORT OF THE DIRECTORS AND

FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2018

FOR

NORTHGATE HEALTHCARE LIMITED

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2018




Page

Company Information 1

Strategic Report 2

Report of the Directors 4

Report of the Independent Auditors 6

Income Statement 8

Other Comprehensive Income 9

Balance Sheet 10

Statement of Changes in Equity 11

Cash Flow Statement 12

Notes to the Cash Flow Statement 13

Notes to the Financial Statements 14


NORTHGATE HEALTHCARE LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2018







DIRECTORS: A K Haines
K Haines
M K Haines





SECRETARY: K Haines





REGISTERED OFFICE: White Gables
Cross Lane Head
Bridgnorth
Shropshire
WV16 4SJ





REGISTERED NUMBER: 05773858 (England and Wales)





AUDITORS: BSS & Co (Accountancy Services) Limited
75 Aston Road
Shifnal
Shropshire
TF11 8DU

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2018

The directors present their strategic report for the year ended 31 December 2018.

We aim to present a balanced and comprehensive review of the development and performance of our business
during the year and its position at the year end. Our review is consistent with the size and non-complex nature of
our business and is written in the context of the risks and uncertainties we face.

REVIEW OF BUSINESS
We are a provider of residential care homes for the elderly and currently own and operate four homes in the
Midlands. We assess the performance for each home separately.

We pride ourselves on the quality of our homes and care we provide. The purchase of Autumn House in 2017,
being our fourth home has seen the group enter the nursing care sector to expand the services and care we are
able to offer across the group.

The occupancy rates across the three specialist dementia homes have been satisfactory over the year with each
home showing good returns in line with our expectations. The transition period into nursing for Autumn House
has had a number of issues which has resulted in only part of the nursing care facility being open during this
year. The profitability of the new home has not been as expected due to this. We have put a number of strategies
in place to move forward with the plans for this home to be a dedicated nursing home.

We have continued with the on-going program of repairs to all homes to ensure they are kept to the high
standards which we continue to meet for all of our service users.

With the addition of nursing care to be provided at our newest home this enables the group to grow the range of
care available to residents across the group. Residential nursing care is a growing sector of our industry and the
directors felt this was a significant addition to the Northgate Healthcare group and although comes with
challenges it will mean residents can continue to receive the high quality care they have been used to from a
Northgate Healthcare home when nursing care is required.

We consider the key financial performance indicators are those that communicate the financial performance and
strength of the company as a whole, these being average occupancy rates, gross profit margin and earnings
before interest, tax, depreciation and amortisation (EBITDA).

We target occupancy rates to be in excess of 95% and this was largely achieved across our three specialist
dementia homes for the year. Autumn House was below our target but following the changes which have been
put in place during 2018 and since the financial year end we are expecting that home will reach our occupancy
targets by the end of 2019. We continue to have high resident retention and satisfaction across all homes in the
group.

The gross profit margin for the company as a whole was 31.65%, a significant reduction from 2017, this was
mainly due to the performance of Autumn House. Our 3 dedicated dementia homes had gross margins of at
least 40% which is in line with our target. We expect our gross margins for 2019 will be much higher than for
2018 overall, with the 3 dementia care homes returning a similar gross profit margin as 2018 and Autumn
House showing a vastly improved results.

PRINCIPAL RISKS AND UNCERTAINTIES
A number of risk factors continue to potentially impact the operating and financial performance of the company.
These being:

- The effects of a further economic downturn which could lead to further pressures on margins
- Changes in the availability of public sector funding. A number of users of the company's care homes rely on
government funding to assist with fees

With these risks and uncertainties in mind, we are aware that any plans for the future development of the
business may be subject to unforeseen events outside of our control.


NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2018

FINANCIAL RISK MANAGEMENT
The company's credit risk is low, being primarily attributed to its trade debtors. All credit risk both publicly and
privately funded is managed by monitoring payments against contractual agreements.

The company faces financial risk from the inflationary pressures from staff costs. Any future changes in the
National Living Wage will have significant impact on labour costs in the care sector as a whole. The company
reviews upcoming changes to the National Living Wage and currently pay above this rate to ensure good quality
care staff. The company plans future wage increases to ensure financial stability of the company going forward
and to ensure these increases does not overly impact cashflow and profitability.

ON BEHALF OF THE BOARD:





A K Haines - Director


30 September 2019

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 DECEMBER 2018

The directors present their report with the financial statements of the company for the year ended 31 December 2018.

DIVIDENDS
The total distribution of dividends for the year ended 31 December 2018 will be £ 243,000 .

FUTURE DEVELOPMENTS
The directors are confident about the continuing financial performance of the business and continue to seek
opportunities to develop the business further.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 January 2018 to the date of
this report.

A K Haines
K Haines
M K Haines

DISCLOSURE IN THE STRATEGIC REPORT
A review of the business, principle risks and uncertainties and financial risk management are included in the
Strategic Report.

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial
statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the
directors have elected to prepare the financial statements in accordance with United Kingdom Generally
Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company
law the directors must not approve the financial statements unless they are satisfied that they give a true and fair
view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing
these financial statements, the directors are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the
company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain
the company's transactions and disclose with reasonable accuracy at any time the financial position of the
company and enable them to ensure that the financial statements comply with the Companies Act 2006. They
are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the
prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the
Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps
that he ought to have taken as a director in order to make himself aware of any relevant audit information and to
establish that the company's auditors are aware of that information.

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 DECEMBER 2018


AUDITORS
The auditors, BSS & Co (Accountancy Services) Limited, will be proposed for re-appointment at the
forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:





A K Haines - Director


30 September 2019

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
NORTHGATE HEALTHCARE LIMITED

Opinion
We have audited the financial statements of Northgate Healthcare Limited (the 'company') for the year ended
31 December 2018 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet,
Statement of Changes in Equity, Cash Flow Statement and Notes to the Cash Flow Statement, Notes to the
Financial Statements, including a summary of significant accounting policies. The financial reporting
framework that has been applied in their preparation is applicable law and United Kingdom Accounting
Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK
and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 31 December 2018 and of its profit for the
year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice;
and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and
applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities
for the audit of the financial statements section of our report. We are independent of the company in
accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK,
including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with
these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to
provide a basis for our opinion.

Conclusions relating to going concern
We have nothing to report in respect of the following matters in relation to which the ISAs (UK) require us to
report to you where:
- the directors' use of the going concern basis of accounting in the preparation of the financial statements is not
appropriate; or
- the directors have not disclosed in the financial statements any identified material uncertainties that may cast
significant doubt about the company's ability to continue to adopt the going concern basis of accounting for a
period of at least twelve months from the date when the financial statements are authorised for issue.

Other information
The directors are responsible for the other information. The other information comprises the information in the
Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of
the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise
explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and,
in doing so, consider whether the other information is materially inconsistent with the financial statements or
our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material
inconsistencies or apparent material misstatements, we are required to determine whether there is a material
misstatement in the financial statements or a material misstatement of the other information. If, based on the
work we have performed, we conclude that there is a material misstatement of this other information, we are
required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Directors for the financial year for which
the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal
requirements.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
NORTHGATE HEALTHCARE LIMITED


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of
the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to
report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received
from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page four, the directors are
responsible for the preparation of the financial statements and for being satisfied that they give a true and fair
view, and for such internal control as the directors determine necessary to enable the preparation of financial
statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to
continue as a going concern, disclosing, as applicable, matters related to going concern and using the going
concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or
have no realistic alternative but to do so.

Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free
from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes
our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in
accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise
from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be
expected to influence the economic decisions of users taken on the basis of these financial statements.

A further description of our responsibilities for the audit of the financial statements is located on the Financial
Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our
Report of the Auditors.

Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the
Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members
those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the
fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and
the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Mr T Afzal A.C.A. (Senior Statutory Auditor)
for and on behalf of BSS & Co (Accountancy Services) Limited
75 Aston Road
Shifnal
Shropshire
TF11 8DU

30 September 2019

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

INCOME STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2018

2018 2017
Notes £    £   

TURNOVER 5,916,081 5,047,701

Cost of sales 4,043,725 3,226,054
GROSS PROFIT 1,872,356 1,821,647

Administrative expenses 1,144,932 871,047
OPERATING PROFIT 4 727,424 950,600

Interest receivable and similar income - 741
727,424 951,341

Interest payable and similar expenses 5 249,730 172,555
PROFIT BEFORE TAXATION 477,694 778,786

Tax on profit 6 71,027 144,316
PROFIT FOR THE FINANCIAL
YEAR

406,667

634,470

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

OTHER COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2018

2018 2017
Notes £    £   

PROFIT FOR THE YEAR 406,667 634,470


OTHER COMPREHENSIVE INCOME
Revaluation surplus
Income tax relating to other
comprehensive income

30,040

28,620
OTHER COMPREHENSIVE INCOME
FOR THE YEAR, NET OF INCOME
TAX


30,040


28,620
TOTAL COMPREHENSIVE INCOME
FOR THE YEAR

436,707

663,090

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

BALANCE SHEET
31 DECEMBER 2018

2018 2017
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 8 913,893 988,721
Tangible assets 9 13,791,582 13,724,414
14,705,475 14,713,135

CURRENT ASSETS
Stocks 10 14,342 11,550
Debtors 11 621,135 475,809
Prepayments and accrued income 35,086 46,438
Cash at bank and in hand 387,157 509,219
1,057,720 1,043,016
CREDITORS
Amounts falling due within one year 12 1,631,620 1,462,758
NET CURRENT LIABILITIES (573,900 ) (419,742 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

14,131,575

14,293,393

CREDITORS
Amounts falling due after more than one
year

13

(8,158,325

)

(8,502,661

)

PROVISIONS FOR LIABILITIES 17 (900,084 ) (911,273 )
NET ASSETS 5,073,166 4,879,459

CAPITAL AND RESERVES
Called up share capital 18 100 100
Revaluation reserve 19 3,413,300 3,383,260
Retained earnings 19 1,659,766 1,496,099
SHAREHOLDERS' FUNDS 5,073,166 4,879,459

The financial statements were approved by the Board of Directors on 30 September 2019 and were signed on its
behalf by:





A K Haines - Director


NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2018

Called up
share Retained Revaluation Total
capital earnings reserve equity
£    £    £    £   

Balance at 1 January 2017 100 1,059,629 3,354,640 4,414,369

Changes in equity
Dividends - (198,000 ) - (198,000 )
Total comprehensive income - 634,470 28,620 663,090
Balance at 31 December 2017 100 1,496,099 3,383,260 4,879,459

Changes in equity
Dividends - (243,000 ) - (243,000 )
Total comprehensive income - 406,667 30,040 436,707
Balance at 31 December 2018 100 1,659,766 3,413,300 5,073,166

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

CASH FLOW STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2018

2018 2017
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 848,600 1,230,190
Interest paid (266,679 ) (154,226 )
Interest element of hire purchase
payments paid

(611

)

(769

)
Tax paid (59,520 ) 37,126
Net cash from operating activities 521,790 1,112,321

Cash flows from investing activities
Purchase of intangible fixed assets - (160,001 )
Purchase of tangible fixed assets (145,278 ) (2,839,731 )
Sale of tangible fixed assets - 729
Interest received - 741
Net cash from investing activities (145,278 ) (2,998,262 )

Cash flows from financing activities
New loans in year - 2,740,500
Loan repayments in year (251,481 ) (285,211 )
Inter company loan - 64
Capital repayments in year (2,865 ) (2,707 )
Amount introduced by directors - 4,001
Amount withdrawn by directors (44,075 ) (96,494 )
Equity dividends paid (243,000 ) (198,000 )
Net cash from financing activities (541,421 ) 2,162,153

(Decrease)/increase in cash and cash equivalents (164,909 ) 276,212
Cash and cash equivalents at beginning
of year

2

509,219

233,007

Cash and cash equivalents at end of
year

2

344,310

509,219

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

NOTES TO THE CASH FLOW STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2018

1. RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM
OPERATIONS
2018 2017
£    £   
Profit before taxation 477,694 778,786
Depreciation charges 152,936 150,854
Profit on disposal of fixed assets - (729 )
Finance costs 249,730 172,555
Finance income - (741 )
880,360 1,100,725
Increase in stocks (2,792 ) (4,850 )
Increase in trade and other debtors (133,974 ) (378,985 )
Increase in trade and other creditors 105,006 513,300
Cash generated from operations 848,600 1,230,190

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect
of these Balance Sheet amounts:

Year ended 31 December 2018
31.12.18 1.1.18
£    £   
Cash and cash equivalents 387,157 509,219
Bank overdrafts (42,847 ) -
344,310 509,219
Year ended 31 December 2017
31.12.17 1.1.17
£    £   
Cash and cash equivalents 509,219 233,007

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2018

1. STATUTORY INFORMATION

Northgate Healthcare Limited is a private company, limited by shares , registered in England and Wales.
The company's registered number and registered office address can be found on the Company
Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover represents the fees derived from the provision of care services to residents during the year.
Income is recognised on a daily basis for the provision of nursing care services.

Goodwill
Goodwill, being the amount paid in connection with acquisition of care homes in 2007, 2010, 2015 and
2017 is being amortised evenly over its estimated useful life of twenty years.


Intangible assets
Intellectual property rights and books of account, being the amount paid in connection with the
acquisition of a care home in 2010, are being amortised evenly over the deemed useful life of twenty
years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Freehold property - not provided
Fixtures fittings & equipment - 10% on reducing balance
Motor vehicles - 25% on reducing balance
Computer equipment - 25% on reducing balance

Freehold property is not depreciated, as it is the opinion of the directors that periodic revaluation in line
with generally accepted accounting principles fairly reflects the fair market value of the properties, and
therefore depreciation is considered to be immaterial.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete
and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement,
except to the extent that it relates to items recognised in other comprehensive income or directly in
equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted
or substantively enacted by the balance sheet date.


NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2018

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the
balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods
different from those in which they are recognised in financial statements. Deferred tax is measured using
tax rates and laws that have been enacted or substantively enacted by the year end and that are expected
to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable
that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet.
Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held
under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the
shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital
element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of
the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's
pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS
2018 2017
£    £   
Wages and salaries 3,641,435 2,930,423
Social security costs 162,138 120,627
Other pension costs 33,852 12,081
3,837,425 3,063,131

The average number of employees during the year was as follows:
2018 2017

Lane House 43 45
The Firs 77 73
Meadowfields 84 76
Autumn House 57 53
261 247

2018 2017
£    £   
Directors' remuneration 17,304 17,304

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2018

4. OPERATING PROFIT

The operating profit is stated after charging/(crediting):

2018 2017
£    £   
Hire of plant and machinery 62,231 46,900
Other operating leases 3,600 3,600
Depreciation - owned assets 75,948 73,146
Depreciation - assets on hire purchase contracts 2,162 2,883
Profit on disposal of fixed assets - (729 )
Goodwill amortisation 74,202 74,201
Intellectual property & books amortisation 626 625
Auditors' remuneration 5,100 5,100

5. INTEREST PAYABLE AND SIMILAR EXPENSES
2018 2017
£    £   
Bank interest 845 -
Bank loan interest 247,794 171,786
Other interest 480 -
Hire purchase 611 769
249,730 172,555

6. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
2018 2017
£    £   
Current tax:
UK corporation tax 52,176 90,945

Deferred tax 18,851 53,371
Tax on profit 71,027 144,316

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2018

6. TAXATION - continued

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is lower than the standard rate of corporation tax in the UK. The difference
is explained below:

2018 2017
£    £   
Profit before tax 477,694 778,786
Profit multiplied by the standard rate of corporation tax in the UK of
19% (2017 - 19.247%)

90,762

149,893

Effects of:
Expenses not deductible for tax purposes 144 623
Capital allowances in excess of depreciation (38,730 ) (55,529 )
Utilisation of tax losses - (4,042 )
Deferred tax movement per note 17 18,851 53,371
Total tax charge 71,027 144,316

Tax effects relating to effects of other comprehensive income

2018
Gross Tax Net
£    £    £   
Revaluation surplus - 30,040 30,040

2017
Gross Tax Net
£    £    £   
Revaluation surplus - 28,620 28,620

7. DIVIDENDS
2018 2017
£    £   
Interim 243,000 198,000

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2018

8. INTANGIBLE FIXED ASSETS
Intellectual
property
Goodwill & books Totals
£    £    £   
COST
At 1 January 2018
and 31 December 2018 1,484,026 12,507 1,496,533
AMORTISATION
At 1 January 2018 503,228 4,584 507,812
Amortisation for year 74,202 626 74,828
At 31 December 2018 577,430 5,210 582,640
NET BOOK VALUE
At 31 December 2018 906,596 7,297 913,893
At 31 December 2017 980,798 7,923 988,721

9. TANGIBLE FIXED ASSETS
Fixtures
Freehold fittings Motor Computer
property & equipment vehicles equipment Totals
£    £    £    £    £   
COST OR VALUATION
At 1 January 2018 13,070,106 907,706 22,000 14,198 14,014,010
Additions 36,520 107,030 - 1,728 145,278
At 31 December 2018 13,106,626 1,014,736 22,000 15,926 14,159,288
DEPRECIATION
At 1 January 2018 - 268,373 12,996 8,227 289,596
Charge for year - 73,934 2,251 1,925 78,110
At 31 December 2018 - 342,307 15,247 10,152 367,706
NET BOOK VALUE
At 31 December 2018 13,106,626 672,429 6,753 5,774 13,791,582
At 31 December 2017 13,070,106 639,333 9,004 5,971 13,724,414

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2018

9. TANGIBLE FIXED ASSETS - continued

Cost or valuation at 31 December 2018 is represented by:

Fixtures
Freehold fittings Motor Computer
property & equipment vehicles equipment Totals
£    £    £    £    £   
Valuation in 2010 672,989 - - - 672,989
Valuation in 2013 979,584 - - - 979,584
Valuation in 2016 2,271,396 - - - 2,271,396
Cost 9,182,657 1,014,736 22,000 15,926 10,235,319
13,106,626 1,014,736 22,000 15,926 14,159,288

If freehold land and buildings had not been revalued they would have been included at the following
historical cost:

2018 2017
£    £   
Cost 9,182,656 9,146,137

Lane House Residential Care Home was revalued on an open market basis on 2 September 2014 by
Knight Frank LLP.

The Firs Residential Care Home and Meadowfield Residential Care Home were revalued on an open
market basis on 20 March 2017 by Knight Frank LLP

The freehold properties were valued as fully equipped operational entities, having regard to their trading
potential.

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:
Motor
vehicles
£   
COST OR VALUATION
At 1 January 2018
and 31 December 2018 20,500
DEPRECIATION
At 1 January 2018 11,852
Charge for year 2,162
At 31 December 2018 14,014
NET BOOK VALUE
At 31 December 2018 6,486
At 31 December 2017 8,648

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2018

10. STOCKS
2018 2017
£    £   
Stocks - food and medical
supplies 14,342 11,550

11. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2018 2017
£    £   
Trade debtors 618,553 473,054
Other debtors 2,582 2,755
621,135 475,809

12. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2018 2017
£    £   
Bank loans and overdrafts (see note 14) 413,327 285,212
Hire purchase contracts (see note 15) 7,585 2,865
Trade creditors 227,758 248,431
Amounts owed to group undertakings 5,924 5,924
Tax 83,601 90,945
Social security and other taxes 50,705 42,660
Other creditors 321,905 263,542
Directors' current accounts 128,193 172,268
Accruals and deferred income 392,622 350,911
1,631,620 1,462,758

13. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN
ONE YEAR
2018 2017
£    £   
Bank loans (see note 14) 8,158,325 8,495,076
Hire purchase contracts (see note 15) - 7,585
8,158,325 8,502,661

14. LOANS

An analysis of the maturity of loans is given below:

2018 2017
£    £   
Amounts falling due within one year or on demand:
Bank overdrafts 42,847 -
Bank loans 370,480 285,212
413,327 285,212

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2018

14. LOANS - continued
2018 2017
£    £   
Amounts falling due between one and two years:
Bank loans - 1-2 years 370,480 395,738

Amounts falling due between two and five years:
Bank loans - 2-5 years 7,787,845 8,099,338

A part of the financing of the acquisition of a new home, there is a capital repayment holiday for 2017
and 2018, with the first capital repayment being made early 2019.

15. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Hire purchase contracts
2018 2017
£    £   
Gross obligations repayable:
Within one year 8,028 3,476
Between one and five years - 8,028
8,028 11,504

Finance charges repayable:
Within one year 443 611
Between one and five years - 443
443 1,054

Net obligations repayable:
Within one year 7,585 2,865
Between one and five years - 7,585
7,585 10,450

Non-cancellable
operating leases
2018 2017
£    £   
Within one year 35,366 32,066
Between one and five years 28,153 71,583
63,519 103,649

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2018

16. SECURED DEBTS

The following secured debts are included within creditors:

2018 2017
£    £   
Bank overdraft 42,847 -
Bank loans 8,528,805 8,780,288
8,571,652 8,780,288

A first legal charge and debenture on freehold property known as Lane House, Lichfield Road,
Tamworth, Staffordshire, The Firs, Wodehouse Lane, Sedgley, West Midlands, Meadowfields
Residential Care Home, Great Haywood, Stafford and land on the north west and south east side of
Pasturefields Lane, Great Haywood, Autumn House and Manor House, Stafford Road, Stone,
Staffordshire,White Gables Cross Lane Head, Bridgnorth Shropshire and all other current and future
assets exists in respect of secured debts in favour of National Westminster Bank PLC.

17. PROVISIONS FOR LIABILITIES
2018 2017
£    £   
Deferred tax 900,084 911,273

Deferred
tax
£   
Balance at 1 January 2018 911,273
Credit reversed to OCI (30,040 )
Timing differences 15,225
Prior year adjustment 3,626
Balance at 31 December 2018 900,084

18. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2018 2017
value: £    £   
100 Ordinary £1 100 100

NORTHGATE HEALTHCARE LIMITED (REGISTERED NUMBER: 05773858)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2018

19. RESERVES
Retained Revaluation
earnings reserve Totals
£    £    £   

At 1 January 2018 1,496,099 3,383,260 4,879,359
Profit for the year 406,667 406,667
Dividends (243,000 ) (243,000 )
Other comprehensive income - 30,040 30,040
At 31 December 2018 1,659,766 3,413,300 5,073,066

The revaluation reserve is solely attributable to the revaluation of freehold property.

20. RELATED PARTY DISCLOSURES

A first legal charge exists in respect of the secured debts in favour of National Westminster Bank PLC on
certain property held by K Haines.

K Haines has also given a personal guarantee against the bank loan and overdraft.

21. ULTIMATE CONTROLLING PARTY

The company is controlled by the Haines family, who wholly own and control Northgate Healthcare
Holdings Limited, a company which owns 100% of the issued share capital of Northgate Healthcare
Limited. Consolidated financial statements, in which this company is included, are publicly available
from the Registrar of Companies, Cardiff.